Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.

Mendis S.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):10-4. doi: 10.1016/j.pcad.2010.01.001.

PMID:
20620420
2.

From Framingham to North Karelia: from descriptive epidemiology to public health action.

Puska P.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):15-20. doi: 10.1016/j.pcad.2010.01.003.

PMID:
20620421
3.

Preface-Global impact of the Framingham Heart Study.

Wilson PW.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):3. doi: 10.1016/j.pcad.2010.03.006. No abstract available.

PMID:
20620418
4.

The global impact of the Framingham Heart Study: editor's introduction.

Greenberg H.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):1-2. doi: 10.1016/j.pcad.2010.05.003. No abstract available.

PMID:
20620417
5.

The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock.

Kengne AP, Turnbull F, MacMahon S.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):45-51. doi: 10.1016/j.pcad.2010.02.010.

PMID:
20620425
6.

From Framingham to the Framework Convention on Tobacco Control.

Yach D.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):52-4. doi: 10.1016/j.pcad.2010.05.001. No abstract available.

PMID:
20620426
7.

The Abu Dhabi Cardiovascular Program: the continuation of Framingham.

Hajat C, Harrison O.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):28-38. doi: 10.1016/j.pcad.2010.05.002.

PMID:
20620423
8.

The Framingham Heart Study: impact on the prevention and control of cardiovascular diseases in India.

Reddy KS, Satija A.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):21-7. doi: 10.1016/j.pcad.2010.02.011.

PMID:
20620422
9.

Interview of William Kannel, MD. Interview by Peter Wilson, Henry Greenberg.

Kannel W.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):4-9. doi: 10.1016/j.pcad.2010.03.007. No abstract available.

PMID:
20620419
10.

Deciphering the causes of cardiovascular and other complex diseases in populations: achievements, challenges, opportunities, and approaches.

Yusuf S, Anand S.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):62-7. doi: 10.1016/j.pcad.2010.02.001.

PMID:
20620428
11.

Blood pressure and cardiovascular disease: tracing the steps from Framingham.

Turnbull F, Kengne AP, MacMahon S.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):39-44. doi: 10.1016/j.pcad.2010.03.002.

PMID:
20620424
12.

The Framingham Heart Study's impact on global risk assessment.

Bitton A, Gaziano TA.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):68-78. doi: 10.1016/j.pcad.2010.04.001.

13.

Framingham Heart Study: the first 20 years.

Oppenheimer GM.

Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):55-61. doi: 10.1016/j.pcad.2010.03.003.

PMID:
20620427
14.

Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.

Creagh D, Neilson S, Collins A, Colwell N, Hinchion R, Drew C, O'Halloran D, Perry IJ.

Ir Med J. 2002 Nov-Dec;95(10):298-301.

PMID:
12542011
15.

Challenges for the management of hypertension in low-resource settings.

Mendis S.

Ethn Dis. 2003 Summer;13(2 Suppl 2):S67-70. Review.

PMID:
13677416
16.

Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.

Mosca L, Edelman D, Mochari H, Christian AH, Paultre F, Pollin I.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):24-34.

PMID:
16417415
17.
19.

Global preventive policies. Strategies at European and worldwide level.

Kotseva K.

Rev Esp Cardiol. 2008 Sep;61(9):960-70. English, Spanish.

20.

Reducing the global burden of cardiovascular disease: the role of risk factors.

Levenson JW, Skerrett PJ, Gaziano JM.

Prev Cardiol. 2002 Fall;5(4):188-99. Review.

Supplemental Content

Support Center